Sacubitril/Valsartan Initiated in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction after Hemodynamic Stabilization: Primary Results of the TRANSITION Study

被引：4

作者：

Wachter, Rolf ^{[1
]}

Senni, Michele ^{[2
]}

Belohlavek, Jan ^{[3
]}

Butylin, Dmytro ^{[4
]}

Noe, Adele ^{[4
]}

Pascual-Figal, Domingo ^{[5
]}

机构：

[1] Univ Hosp Leipzig, Leipzig, Germany

[2] Hosp Papa Giovanni XXIII, Bergamo, Italy

[3] Charles Univ Prague, Prague, Czech Republic

[4] Novartis Pharma AG, Basel, Switzerland

[5] Univ Murcia, Hosp Univ Virgen de la Arrixaca, Murcia, Spain

来源：

关键词：

D O I：

10.1016/j.cardfail.2018.07.045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

031

引用

页码：S15 / S15

页数：1